Glucocorticoids target suppressor of cytokine signaling 1 (SOCS1) and type 1 interferons to regulate Toll-like receptor-induced STAT1 activation
about
Does Inhalation of Virgin Coconut Oil Accelerate Reversal of Airway Remodelling in an Allergic Model of Asthma?Network analysis identifies a putative role for the PPAR and type 1 interferon pathways in glucocorticoid actions in asthmaticsA single E627K mutation in the PB2 protein of H9N2 avian influenza virus increases virulence by inducing higher glucocorticoids (GCs) level.Glucocorticoid-induced S-adenosylmethionine enhances the interferon signaling pathway by restoring STAT1 protein methylation in hepatitis B virus-infected cells.Effect of prednisone on type I interferon signature in rheumatoid arthritis: consequences for response prediction to rituximab.Transcriptional Profiling of Host Gene Expression in Chicken Embryo Fibroblasts Infected with Reticuloendotheliosis Virus Strain HA1101.SOCS, Inflammation, and Autoimmunity.IFN-γ-induced JAK/STAT, but not NF-κB, signaling pathway is insensitive to glucocorticoid in airway epithelial cells.Type 1 interferons suppress accelerated osteoclastogenesis and prevent loss of bone mass during systemic inflammatory responses to Pneumocystis lung infection.Peripheral Blood Cells from Patients with Autoimmune Addison's Disease Poorly Respond to Interferons In Vitro, Despite Elevated Serum Levels of Interferon-Inducible Chemokines.A MyD88-JAK1-STAT1 complex directly induces SOCS-1 expression in macrophages infected with Group A Streptococcus.Psychological stress and aging: role of glucocorticoids (GCs)Altered signaling in systemic juvenile idiopathic arthritis monocytes.A lethal disease model for hantavirus pulmonary syndrome in immunosuppressed Syrian hamsters infected with Sin Nombre virus.The HPA - Immune Axis and the Immunomodulatory Actions of Glucocorticoids in the Brain.Reduced levels of CCL2 and CXCL10 in systemic lupus erythematosus patients under treatment with prednisone, mycophenolate mofetil, or hydroxychloroquine, except in a high STAT1 subset.MicroRNA-142 regulates inflammation and T cell differentiation in an animal model of multiple sclerosis.The neuroendocrine control of the innate immune system in health and brain diseases.Regulation of Toll-like receptor signaling pathways in innate immune responses.Role of transcription factors in the pathogenesis of asthma and COPD.Reduced frequency of murine cytomegalovirus retinitis in C57BL/6 mice correlates with low levels of suppressor of cytokine signaling (SOCS)1 and SOCS3 expression within the eye during corticosteroid-induced immunosuppression.Double-stranded RNA induces biphasic STAT1 phosphorylation by both type I interferon (IFN)-dependent and type I IFN-independent pathwaysSalivary IL-21 and IgA responses to a competitive match in elite basketball players.Plasmodium berghei NK65 in Combination with IFN-γ Induces Endothelial Glucocorticoid Resistance via Sustained Activation of p38 and JNK.Therapeutic Potential for Targeting the Suppressor of Cytokine Signalling-1 Pathway for the Treatment of SLE.High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway.Differential expression of the Toll-like receptor pathway and related genes of chicken bursa after experimental infection with infectious bursa disease virus.Virus-drug interactions--molecular insight into immunosuppression and HCV.The suppression of TRIM21 and the accumulation of IFN-α play crucial roles in the pathogenesis of osteonecrosis of the femoral head.Kudzu Leaf Extract Suppresses the Production of Inducible Nitric Oxide Synthase, Cyclooxygenase-2, Tumor Necrosis Factor-Alpha, and Interleukin-6 via Inhibition of JNK, TBK1 and STAT1 in Inflammatory Macrophages.Disease-Specific Integration of Omics Data to Guide Functional Validation of Genetic Associations.Brief Report: Identification of a Pathogenic Variant in TREX1 in Early-Onset Cerebral Systemic Lupus Erythematosus by Whole-Exome Sequencing
P2860
382ab99aed9df5eac75df9b08e4c8ca01bf7905539ae8f75d9014eddb964184eb9afc6df1aa8efe35be0d589809398bb7cdf3b7f10b4168d6ec170fe9395d8a3d85f0e702dd29f72b3050b8002d9297e9a4aff9703c650abb9998ad703099c4fa90c640d9ccf4e6d00ca18753a64fcfce97306274ba4bd14b34a9efebf06afb4022f6ec60370c184bb04e5a2b9f773583252cad7f4456c5bc21fae97fd432c92e9bb49787a3cb6f1cda732cc186726b8cdec30d3ebb9eb5080729d662934cd84f5525112b5ffd35cf8af509c7b247ce76243e2dcba08f7f88ee31fe3
P248
Q33808911-638501D5-E39D-4A6C-A982-1A05FF4232A8Q34309219-8BEB43A9-A16A-45B9-A8EE-682843F72E9CQ34311835-8AA9984B-3791-4455-B293-A4C603C6DECAQ34552627-20105703-67BA-4E8C-94D3-EEAED9B05EBBQ35559143-CD6ECAE0-34DB-4B05-ABAB-CE50DEC0DF74Q35631352-EBE0B363-09A3-431E-8BEB-E06B44D23674Q35927538-80842408-0F26-4456-A068-E8B490A18AEAQ35959846-A95287F9-FE9B-4370-B7BA-AB850DF51B8DQ36071793-5F39DEF7-3A1F-46A1-959D-29BF35BC6223Q36108080-6AD272AB-3CBB-4776-88D4-A57B53B04F3BQ36302666-FF8DEFF8-22EE-46E3-B970-D435B07DD5A3Q36483144-A8BF4231-1DC5-449B-BB8D-DCDC5B8DB0CAQ36578742-C5DF860E-C31E-4DBE-85A2-A6C9EB4398C7Q37547578-F6C3526D-87B7-47D2-9D73-7DC6C193CB38Q37689538-B7089B5E-9F1B-46D5-9F44-A398270A4C4AQ37689745-D7D46EAA-3B99-44AD-AA49-51188ED1786EQ37708294-2AE92738-7289-4F8F-AFDB-892C36307307Q38020956-3E31A5B5-9D4F-4D35-890F-6A6C8DD39260Q38060805-53C37F76-26FC-40C9-9BAF-85C5F9A91243Q38087650-D33C969C-75C0-4D70-87FA-23CC6C088C85Q38756226-B66F085C-269A-47CE-9255-10B1390B1BDCQ39279869-61FF7291-87F1-4DF8-9A76-E94A8B79BDE0Q42003932-C3B09729-6C9B-429B-8FF0-F2F0C3031588Q42369143-DE560167-1A9A-443A-967C-29F40532F556Q42787245-2247DFC8-F0DE-46E6-9460-C3433BE102B4Q45163458-B7F9EE6E-3884-4BEC-AF8F-4DAF5DC824BDQ45355961-17C45F9B-9139-4075-9A81-0AA75EBD1007Q45358300-1FA6C4CB-4827-4A25-98C0-C928183451CBQ54299597-BEF6C2FA-EBF0-4183-A108-200816B4F97BQ54951736-878983DB-BB9C-4FE6-8414-AB15D5F73719Q55056641-CE0D65BD-AFF2-4EAE-B1BE-50664EE1B1F4Q57272352-EEAD3292-7DDE-46BE-972C-6451F784054B
P2860
Glucocorticoids target suppressor of cytokine signaling 1 (SOCS1) and type 1 interferons to regulate Toll-like receptor-induced STAT1 activation
description
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
article publié dans les Procee ...... f the United States of America
@fr
artículu científicu espublizáu en 2011
@ast
im Juni 2011 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2011/06/07)
@sk
vědecký článek publikovaný v roce 2011
@cs
wetenschappelijk artikel (gepubliceerd op 2011/06/07)
@nl
наукова стаття, опублікована в червні 2011
@uk
name
Glucocorticoids target suppres ...... eptor-induced STAT1 activation
@ast
Glucocorticoids target suppres ...... eptor-induced STAT1 activation
@en
Glucocorticoids target suppres ...... eptor-induced STAT1 activation
@nl
type
label
Glucocorticoids target suppres ...... eptor-induced STAT1 activation
@ast
Glucocorticoids target suppres ...... eptor-induced STAT1 activation
@en
Glucocorticoids target suppres ...... eptor-induced STAT1 activation
@nl
prefLabel
Glucocorticoids target suppres ...... eptor-induced STAT1 activation
@ast
Glucocorticoids target suppres ...... eptor-induced STAT1 activation
@en
Glucocorticoids target suppres ...... eptor-induced STAT1 activation
@nl
P2093
P2860
P921
P356
P1476
Glucocorticoids target suppres ...... eptor-induced STAT1 activation
@en
P2093
Louis J. Muglia
Sandip Bhattacharyya
Thomas W. H. Kay
Yuxing Zhao
P2860
P304
P356
10.1073/PNAS.1017296108
P407
P577
2011-06-07T00:00:00Z